搜索筛选:
搜索耗时3.5791秒,为你在为你在102,285,761篇论文里面共找到 2 篇相符的论文内容
发布年度:
Phase 1/2 study of nivolumab with or without ipilimumab for treatment of recurrent SCLC:CA209-032 (N
[会议论文] 作者：FilippoDebraud[6]Patricka.Ott[7]M.catherinePietanza[8]LeoraHorn[9]Dungt.Le[10]Michaela.Morse[11]Joséa.López-martin,
来源：第十八届全国临床肿瘤学大会暨2015年CSCO学术年会 年份：2015
Objective: Patients (pts) with SCLC respond to initial platinum (PLT) based chemotherapy (CT), but rapidly progress.Combined blockade of programmed death-1...
Phase 1/2 study of nivolumab with or without ipilimumab for treatment of recurrent SCLC:CA209-032 (N
[会议论文] 作者：iger,Filippo De braud,Patrick a.Ott,M.catherine Pietanza,Leora Horn,Dung t.Le,Michael a.Morse,José a.López-martin,
来源：第十八届全国临床肿瘤学大会暨2015年CSCO学术年会 年份：2015
Objective: Patients (pts) with SCLC respond to initial platinum (PLT) based chemotherapy (CT), but rapidly progress.Combined blockade of programmed death-1 (PD-1) and cytotoxic T-lymphocyte antigen-4...
相关搜索：
